Toronto Dominion Bank Increases Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Toronto Dominion Bank raised its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 6.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 66,997 shares of the company's stock after purchasing an additional 4,218 shares during the quarter. Toronto Dominion Bank owned 0.05% of Henry Schein worth $4,636,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. GF Fund Management CO. LTD. acquired a new position in Henry Schein in the fourth quarter valued at about $194,000. Investment Management Corp VA ADV purchased a new position in Henry Schein in the fourth quarter valued at $32,000. Ananym Capital Management LP acquired a new position in Henry Schein during the 4th quarter worth approximately $32,628,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Henry Schein by 1.5% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 906,304 shares of the company's stock valued at $62,716,000 after purchasing an additional 13,618 shares during the last quarter. Finally, Worldquant Millennium Advisors LLC purchased a new stake in shares of Henry Schein in the 4th quarter valued at approximately $2,308,000. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Stock Performance

Shares of NASDAQ HSIC traded up $1.01 during midday trading on Tuesday, reaching $70.57. 2,191,309 shares of the company were exchanged, compared to its average volume of 1,681,082. The stock has a market cap of $8.59 billion, a P/E ratio of 29.04, a PEG ratio of 2.13 and a beta of 0.87. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The stock has a fifty day simple moving average of $67.67 and a 200 day simple moving average of $71.69. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. During the same quarter in the prior year, the business earned $1.10 earnings per share. The company's quarterly revenue was down .1% compared to the same quarter last year. On average, research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on HSIC shares. Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Wells Fargo & Company decreased their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Barrington Research cut their price target on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 6th. Piper Sandler reduced their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research report on Wednesday, April 30th. Finally, UBS Group dropped their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $79.30.

Insider Transactions at Henry Schein

In other news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This represents a 6.05% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.08% of the company's stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.